View Post

Herpes Vaccine Candidate Launches Early-Phase Study

In COVID-19, Latest News by Precision Vaccinations

Massachusetts-based Rational Vaccines Inc. today announced the launch of an observational clinical trial designed to determine the baseline characteristics of patients diagnosed with recurrent symptomatic herpes simplex virus type 2 (HSV-2).
In addition to assessing the typical baseline characteristics of a population, the purpose of this study is also to determine the acceptance of clinical trial procedures and understand the interest of the target patient population to participate in a therapeutic Phase 1/2 HSV-2 vaccine study in humans.

View Post

New Yorkers Confronting COVID-19, Monkeypox, and Polio Outbreaks

In Travel Vaccine News by Travel Vaccine

Over the past few months, lower New York residents have been confronting the ongoing COVID-19 pandemic, an expanding number of monkeypox virus infections, and, recently, poliovirus detections.
The good news is that these diseases can be prevented with U.S. FDA-approved vaccines.
"For every one case of paralytic polio identified, hundreds more may be undetected," New York State Health Commissioner Dr. Mary T. Bassett said in a related press release on August 12, 2022.

View Post

Influenza Antiviral Works Before and After Annual Flu Shots

In Influenza Vaccine News by Influenza Vaccine

As the flu season approaches from the Southern Hemisphere this year, plenty of U.S. FDA-approved influenza vaccines are available to protect people.
However, anyone can get the flu before they are vaccinated, and occasionally even after.
To help reduce the severity of influenza in children, the FDA recently extended the use of a leading oral antiviral medicine.